SCHEMBL22145201

SCHEMBL22145201

COc1ccc(-n2c3ccccc3c3c4ccccc4c4c(c32)C=CC(c2ccc(OC)cc2)(c2ccc(OC)cc2)O4)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
LMNA P02545 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
EDNRA P25101 1/20 0.35
DRD1 P21728 1/20 0.32
DRD5 P21918 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ATM Q13315 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
METAP2 P50579 1/20 0.31
CA9 Q16790 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145205 0.97 EDNRA (0.34) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL22145135 0.97 EDNRA (0.36) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL22145126 0.93 PPARG (0.38) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL22145207 0.92 KDM4E (0.33) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL23919130 0.91 MAPT (0.36) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL22145210 0.91 ALDH1A1 (0.31) MAPTLMNAALDH1A1HPGDEDNRA
SCHEMBL22145250 0.90 KDM4E (0.36) MAPTLMNAALDH1A1HPGDSMN1; SMN2
SCHEMBL22145193 0.89
SCHEMBL22145211 0.89 POLB (0.31) MAPT
SCHEMBL22145204 0.89 L3MBTL1 (0.31) LMNAALDH1A1HPGDEDNRAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 MAPT 1575/4885LMNA 2683/4885ALDH1A1 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.